Single-center, Randomized, Double-blind, Placebo-controlled, Parallel-groups Study of Lubiprostone in Patients With Multiple Sclerosis-Associated Constipation.

Trial Profile

Single-center, Randomized, Double-blind, Placebo-controlled, Parallel-groups Study of Lubiprostone in Patients With Multiple Sclerosis-Associated Constipation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Dec 2015

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation; Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top